FDA reviews BPC-157, TB-500 and other peptides favored by RFK Jr.
The FDA is convening a panel to review the safety and efficacy of peptides, which have gained popularity as wellness supplements despite a lack of clinical evidence. The review is politically charged due to support from Health Secretary Robert F. Kennedy Jr. and various wellness influencers.
Why it matters
The debate highlights a growing tension between government regulatory bodies and the 'wellness' industry, particularly regarding the oversight of unproven medical substances.
Add AP News as your preferred source to see more of our stories on Google. --> Share
WASHINGTON (AP) — Health advisers begin meeting Thursday to review more than a half-dozen peptides , unproven substances that have become a growing wellness trend despite little evidence they are safe or effective.
The two-day meeting hosted by the Food and Drug Administration has the backing of Health Secretary Robert F. Kennedy Jr. , who has described himself as a “big fan” of peptides and vowed to overturn industry restrictions put in place under President Joe Biden.
Peptide supporters include podcaster Joe Rogan and wellness influencers such as Gary Brecka , a supporter of Kennedy’s “Make America Healthy Again” agenda who sells peptide vials online. Social media platforms are brimming with testimonials from people claiming the substances helped them build muscle, recover from injuries or look younger.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in